BioXell
BioXell is a biomedical research institute focusing on chronic inflammatory disease and autoimmunity.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed BioXell Information
BioXell was acquired by
Cosmo Pharmaceuticals.
The acquisition happend on 2009-11-18.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Milan
State: Lombardia
Zip:
Country: Italy
Financial Info
Stage:
series c
Raised Last:
$13M
Raised Total:$81M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
BioXell was founded in 2002 as a spinout of Roche Milano Ricerche, a leading biomedical research institute created ten years earlier that focused on chronic inflammatory disease and autoimmunity. The idea to create BioXell originated with Francesco Sinigaglia, founder and director of the Milan-based research institute, following a scientific career path that took him to the University College in London, the Basel Institute of Immunology and the Hoffmann-La Roche research units in Basel. Dr. Sinigaglia, former CEO, approached Roche with his challenging project and a year later BioXell was spun off, with $22m invested by MPM Capital, Index Ventures and Life Science Partners.
Contact Phone:
Contact Email:
BioXell went public on 6/9/2006 on the SWX
Listed Exchange:
SWX
IPO Date:
6/9/2006
Ticker Symbol:
BXLN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2006 | Series C | 4 | $12.7M |
BB Biotech Ventures Index Ventures MVM Life Science Partners TVM Capital BB Biotech Ventures Index Ventures MVM Life Science Partners TVM Capital |
1/2002 | Series A | 3 | $19.7M |
Index Ventures MPM Capital MVM Life Science Partners Index Ventures MPM Capital MVM Life Science Partners |
5/2003 | Series B | 3 | $19.9M |
Index Ventures Life Sciences Partners MPM Capital Index Ventures Life Sciences Partners MPM Capital |
10/2004 | Series C | 7 | $29M |
AlpInvest Partners BB Biotech Ventures Index Ventures MPM Capital MVM Life Science Partners NIF Ventures QVentures AlpInvest Partners BB Biotech Ventures Index Ventures MPM Capital MVM Life Science Partners NIF Ventures QVentures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
